2019 tables: Institutions - chemistry - corporate

The 2019 tables are based on Nature Index data from 1 January 2018 to 31 December 2018.

Table criteria

Request a badge Export CSV
# Institution Share 2017 Share 2018 Count 2018 Change in Adjusted Share* 2017–2018
1 F. Hoffmann-La Roche AG, Switzerland 16.85 15.16 32 -15.4%
2 AstraZeneca plc, United Kingdom (UK) 10.93 10.87 52 -6.4%
3 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 7.50 7.74 21 -2.9%
4 Novartis International AG, Switzerland 11.74 6.74 27 -46.0%
5 BASF SE, Germany 6.69 6.41 32 -10.0%
6 UCB S.A., Belgium 1.83 4.20 11 115.3%
7 C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim), Germany 4.07 4.08 9 -5.8%
8 Bayer AG, Germany 1.74 3.57 13 92.7%
9 Sanofi, France 1.81 3.29 5 70.5%
10 Center for Nanotechnology GmbH (CeNTech GmbH), Germany 2.26 2.83 15 17.6%
11 Sociedad Europea de Análisis Diferencial de Movilidad SL (SEADM), Spain – 2.56 4 N/A
12 Johnson Matthey (JM), United Kingdom (UK) 1.64 2.34 7 33.9%
13 Novo Nordisk A/S, Denmark 2.48 2.06 6 -21.9%
14 Metrohm DropSens S.L., Spain 1.00 2.00 2 88.0%
15 Merck KGaA, Germany 2.71 1.93 12 -32.8%
16 Thales S.A., France 1.23 1.90 16 44.9%
17 Haldor Topsøe A/S, Denmark 2.14 1.53 6 -32.7%
18 Pierre Fabre SA, France 0.20 1.43 7 570.3%
19 Bracco Imaging S.p.A., Italy 0.18 1.41 3 641.9%
20 Evonik Industries AG, Germany 0.96 1.37 9 33.3%
21 Goodyear Innovation Center, Luxembourg – 1.24 2 N/A
22 Austrian Centre of Industrial Biotechnology (ACIB), Austria 1.15 1.08 7 -12.2%
23 ams-OSRAM AG, Austria 0.13 1.05 4 691.6%
24 Tofwerk AG, Switzerland 0.33 1.02 4 186.1%
25 Lumileds Holding B.V., Netherlands – 0.99 4 N/A
26 AMO GmbH, Germany – 0.83 4 N/A
27 Total S.A., France 1.44 0.83 5 -46.2%
28 Saint-Gobain SA, France 0.07 0.82 5 1071.5%
29 Umicore N.V., Belgium 0.17 0.81 3 356.0%
30 Arkema S.A., France 1.26 0.78 3 -41.9%
31 AIT Austrian Institute of Technology GmbH, Austria 2.92 0.77 6 -75.2%
32 Ulisse BioMed SRL, Italy – 0.73 2 N/A
33 Neem Biotech Ltd., United Kingdom (UK) – 0.71 1 N/A
34 Unilever, United Kingdom (UK) 0.68 0.71 1 -1.7%
35 Abzena PLC, United Kingdom (UK) – 0.70 1 N/A
36 Bruker BioSpin GmbH, Germany 0.85 0.69 4 -24.4%
37 Infineum International Ltd., United Kingdom (UK) 0.20 0.67 2 213.4%
38 Ivoclar Vivadent AG, Liechtenstein 0.53 0.66 4 17.1%
39 Genos Ltd., Croatia – 0.63 1 N/A
40 Enamine Ltd., Ukraine 0.94 0.61 2 -39.0%
41 allnex, Belgium – 0.60 1 N/A
42 Prozomix Limited, United Kingdom (UK) – 0.60 2 N/A
43 EN-FIST Centre of Excellence, Slovenia 0.23 0.58 5 135.1%
43 Solvay S.A., Belgium 2.83 0.58 2 -80.6%
44 ABB Ltd., Switzerland 0.46 0.56 2 16.1%
45 Idorsia Pharmaceuticals Ltd., Switzerland 1.00 0.56 2 -47.6%
46 Alfasigma S.p.A., Italy – 0.55 1 N/A
47 Robert Bosch GmbH, Germany 0.18 0.53 7 171.6%
48 MIP Diagnostics Ltd., United Kingdom (UK) 0.18 0.50 2 159.3%
48 GlycoThera GmbH, Germany – 0.50 1 N/A
48 Unit DX, United Kingdom (UK) – 0.50 1 N/A
48 IRsweep GmbH, Switzerland – 0.50 1 N/A
48 CNH Industrial N.V., Netherlands – 0.50 2 N/A
48 Symeres, Netherlands – 0.50 2 N/A
48 Alphalyse A/S, Denmark – 0.50 1 N/A
49 Research Institutes of Sweden (RISE), Sweden 1.04 0.46 10 -58.2%
50 Signatope GmbH, Germany – 0.46 2 N/A

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals through 2022, in 2023 64 health-science journals were added to the Index. The 146 journals in the Nature Index were selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.
  5. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2022 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.